Gender gap in cystic fibrosis mortality

American Journal of Epidemiology

Volumn 145, Issue 9, 1997, Pages 794-803

  Rosenfeld, Margaret ^a,e   Davis, Robert ^a,b   FitzSimmons, Stacey ^c   Pepe, Margaret ^d   Ramsey, Bonnie ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CYSTIC FIBROSIS FOUNDATION   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

cystic fibrosis; epidemiologic factors; mortality; sex factors; survival analysis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CYSTIC FIBROSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE;

EID: 0030967472     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009172     Document Type: Article

References (41)

1. FitzSimmons S. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9.
2. Cystic Fibrosis Foundation. Patient registry 1992 annual data report. Bethesda, MD: Cystic Fibrosis Foundation, October 1993.
3. Canada Cystic Fibrosis Foundation. Report of the Canadian patient data registry 1989. Toronto: Canada Cystic Fibrosis Foundation, 1990.
4. Warwick WJ, Pogue RE, Gerber HU, et al. Survival patterns in cystic fibrosis. J Chron Dis 1975;28:609-22.
5. Dodge JA, Morison S, Lewis PA, et al. Cystic fibrosis in the United Kingdom, 1968-1988: incidence, population and survival. Paediatr Perinat Epidemiol 1993;7:157-66.
6. Gurwitz D, Corey M, Francis PW, et al. Perspectives in cystic fibrosis. Pediatr Clin North Am 1979;26:603-15.
7. British Paediatric Association Working Party on Cystic Fibrosis. Cystic fibrosis in the United Kingdom 1977-85: an improving picture. BMJ 1988;297:1599-601.
8. Britton, J. Effects of social class, sex, and region of residence on age at death from cystic fibrosis. BMJ 1989;298:483-7.
9. Kerem E, Reisman J, Corey M, et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326: 1187-91.
10. Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995;48:1041-9.
11. Corey M, McLaughlin FJ, Williams M, et al. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988; 41:583-91.
12. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959;23:545-9.
13. Tsui LC. Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: a report from the Cystic Fibrosis Genetic Analysis Consortium. Hum Mutat 1992;1:197-203.
14. American Society for Microbiology. Manual of clinical microbiology. 2nd ed. Washington, DC: American Society for Microbiology, 1974:66-8.
15. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically: approved standard M7-A2. Villanova, PA: National Committee for Clinical Laboratory Standards, 1990.
16. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-18.
17. Knudson RJ, Lebowitz, MD, Holberg CJ, et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-34.
18. Dibley MJ, Goldsby JB, Staehling NW, et al. Development of normalized curves for the international growth reference: historical and technical considerations. Am J Clin Nutr 1987;4: 736-48.
19. Centers for Disease Control Division of Nutrition. Anthropometric statistical package, batch/entry file conversion program. Atlanta, GA: Agency for International Development Office of Nutrition, 1990. (Publication no. RSSA #BST-1064-12-HC-2174-03).
20. Moore DJ, Durie PR, Forstner GG, et al. The assessment of nutritional status in children. Nutr Res 1985;5:797-9.
21. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc Series B 1972;34:187-202.
22. Corey M. Survival estimates in cystic fibrosis: snapshots of a moving target. Pediatr Pulmonol 1996;21:149-50.
23. SAS/UNIX 6.10. Cary, NC: SAS Institute, 1995.
24. SPSS for windows 6.0. Chicago, IL: SPSS, Inc., 1993.
25. STATA version 3.1. College Station, TX: STATA Corporation, 1993.
26. Huang NS, Macri CN, Girone J, et al. Survival of patients with cystic fibrosis. Am J Dis Child 1970;120:289-95.
27. Knoke JD, Stern RC, Doershuk CF, et al. Cystic fibrosis: the prognosis for five-year survival. Pediatr Res 1978;12:676-9.
28. Hill DJ, Martin AJ, Davidson GP, et al. Survival of cystic fibrosis patients in South Australia. Med J Aust 1985;143: 230-2.
29. Nielsen OH, Thomsen BI, Green A, et al. Cystic fibrosis in Denmark 1945 to 1985. Acta Paediatr Scand 1988;77: 836-41.
30. Wilmott RW, Tyson SL, Dinwiddie R, et al. Survival rates in cystic fibrosis. Arch Dis Child 1983;58:835-6.
31. Wilmott RW, Tyson SL, Matthew DJ. Cystic fibrosis survival rates: the influences of allergy and Pseudomonas aeruginosa. Am J Dis Child 1985;139:669-71.
32. Huang NN, Schidlow DV, Szatrowski TH, et al. Clinical features, survival rate and prognostic factors in young adults with cystic fibrosis. Am J Med 1987;82:871-9.
33. Hudson I, Phelan PD. Are sex, age at diagnosis, or mode of presentation prognostic factors for cystic fibrosis? Pediatr Pulmonol 1987;3:288-97.
34. Cystic Fibrosis Foundation. Patient registry 1994 annual data report. Bethesda, MD: Cystic Fibrosis Foundation, October 1995.
35. Cystic Fibrosis Foundation. Patient registry 1995 annual data report. Bethesda, MD: Cystic Fibrosis Foundation, October 1996.
36. Craman PS, Hall CB. Epidemiology and control of nosocomial viral infections. Infect Dis Clin North Am 1989;3: 815-41.
37. Department of Economic and Social Affairs, Statistical Office, United Nations. Demographic yearbook, 1993. New York, NY: United Nations Press, 1993.
38. Ramsey BW, Farrell PM, Pencharz P, et al. Nutritional assessment and management in cystic fibrosis: a consensus report. Am J Clin Nutr 1992;55:108-16.
39. Lewin LO, Byard PJ, Davis PB. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol 1990;43:125-31.
40. Orenstein DM, Nixon PA. Exercise performance and breathing patterns in cystic fibrosis: male-female differences and influence of resting pulmonary function. Pediatr Pulmonol 1991;10:101-5.
41. Smyth A, O'Hea U, Williams G, et al. Passive smoking and impaired lung function in cystic fibrosis. Arch Dis Child 1994;71:353-4.